Tune Therapeutics launches with $40M in funding, aims to fine-tune activity of genes in cells by Charlotte Schubert on December 2, 2021December 3, 2021 at 8:33 am A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40 million in new funding and a leadership team peppered with veterans of Seattle cell therapy… Read More